Cite
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population
MLA
Braden Millan, et al. “Comparison of Patients with Renal Cell Carcinoma in Adjuvant Therapy Trials to a Real-World Population.” Urologic Oncology: Seminars and Original Investigations, May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b38b26a690336e9a0a88a1a0ac20d397&authtype=sso&custid=ns315887.
APA
Braden Millan, Rodney H. Breau, Ranjeeta Mallick, Lori Wood, Ricardo Rendon, Antonio Finelli, Alan I. So, Luke T. Lavallée, Frédéric Pouliot, Bimal Bhindi, Daniel Heng, Darrel Drachenberg, Simon Tanguay, Lucas Dean, Naveen S. Basappa, Jean-Baptiste Lattouf, George Bjarnason, Aly-Khan Lalani, & Anil Kapoor. (2023). Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population. Urologic Oncology: Seminars and Original Investigations.
Chicago
Braden Millan, Rodney H. Breau, Ranjeeta Mallick, Lori Wood, Ricardo Rendon, Antonio Finelli, Alan I. So, et al. 2023. “Comparison of Patients with Renal Cell Carcinoma in Adjuvant Therapy Trials to a Real-World Population.” Urologic Oncology: Seminars and Original Investigations, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b38b26a690336e9a0a88a1a0ac20d397&authtype=sso&custid=ns315887.